A global strategy for prevention and detection of blood doping with erythropoietin and related drugs.

The definition blood doping was introduced by the media in the 1970s to describe the use of blood transfusion to increase red cell mass artificially, and in turn to enhance both maximal oxygen uptake and performance in endurance sports. Since the late 1980s blood doping is no longer achieved by autologous transfusion but instead through administration of recombinant human erythropoietin (rHuEpo).